A panelist discusses how a large propensity score–matched analysis of 1300 patients aged 60-75 found similar all-cause mortality between intensive chemotherapy and azacitidine plus venetoclax, but ...
TCT 464: A Novel Approach to Treat and Reverse Moderate/Servere Heart Failure to NYHA I-II Using Direct Electrical Microcurrent Receive the the latest news, research, and presentations from major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results